$GRST
ETHEMA HEALTH Corp Stock $grst

$grst Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000190359624000279 Filed on May 07, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023
Revenue	$1.490M	$1.125M	$5.345M
YoY Change	-4.84%	-8.86%	10.87%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.656M	$1.697M	$5.388M
YoY Change	18.74%	71.46%	42.11%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$22.59K	$110.7K	$498.9K
YoY Change	-83.82%	-19.39%	-7.63%
% of Gross Profit
Operating Expenses	$1.768M	$1.808M	$5.887M
YoY Change	15.24%	60.4%	35.9%
Operating Profit	-$277.5K		-$541.9K
YoY Change	-963.28%		-210.8%
Interest Expense	-$187.8K	-$171.0K	-$875.9K
YoY Change	-41.2%	-272.54%	517.55%
% of Operating Profit
Other Income/Expense, Net		-$10.45K
YoY Change		-279.55%
Pretax Income	-$465.3K	-$864.1K	$614.5K
YoY Change	3.05%	-667.34%	50.82%
Income Tax		-$170.9K	$392.0K
% Of Pretax Income			63.79%
Net Earnings	-$363.4K	-$395.2K	$1.006M
YoY Change	56.55%	-462.67%	306.01%
Net Earnings / Revenue	-24.39%	-35.12%	18.83%
Basic Earnings Per Share	$0.00
Diluted Earnings Per Share	$0.00	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	3.729B shares	3.729B shares
Diluted Shares Outstanding	3.729B shares

Balance Sheet

Concept	2024 Q2	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$31.10K	$68.57K	$68.57K
YoY Change	11.83%	-51.29%	-51.29%
Cash & Equivalents	$31.10K	$68.57K
Short-Term Investments
Other Short-Term Assets	$1.478K	$3.030K	$21.19K
YoY Change	-97.33%	-85.11%	-67.44%
Inventory
Prepaid Expenses	$26.45K	$18.16K
Receivables	$272.9K	$313.3K	$313.3K
Other Receivables	$13.57K	$0.00	$0.00
Total Short-Term Assets	$345.5K	$403.1K	$403.1K
YoY Change	-40.43%	-25.75%	-25.75%
LONG-TERM ASSETS
Property, Plant & Equipment	$763.0K	$508.4K	$9.832M
YoY Change	43.61%	-82.91%	125.12%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$472.4K	$389.0K	$389.0K
YoY Change	18.1%	-2.75%	-2.75%
Total Long-Term Assets	$12.00M	$11.12M	$11.12M
YoY Change	268.71%	84.64%	84.64%
TOTAL ASSETS
Total Short-Term Assets	$345.5K	$403.1K	$403.1K
Total Long-Term Assets	$12.00M	$11.12M	$11.12M
Total Assets	$12.35M	$11.52M	$11.52M
YoY Change	221.97%	75.51%	75.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$507.9K	$352.1K	$352.1K
YoY Change	287.0%	105.99%	105.99%
Accrued Expenses	$275.5K	$38.56K	$38.56K
YoY Change	-11.5%	-86.57%	-86.57%
Deferred Revenue
YoY Change
Short-Term Debt	$2.379M	$680.7K	$7.673M
YoY Change	199.81%	47.8%	-9.13%
Long-Term Debt Due	$2.461M	$23.39K	$23.39K
YoY Change	10562.26%	-99.34%	-99.34%
Total Short-Term Liabilities	$8.546M	$8.299M	$8.299M
YoY Change	-13.3%	-37.55%	-37.55%
LONG-TERM LIABILITIES
Long-Term Debt	$1.952M	$37.00K	$37.00K
YoY Change	206.44%	-94.58%	-94.58%
Other Long-Term Liabilities	$9.991M	$9.384M	$9.384M
YoY Change	859.05%	677.81%	677.81%
Total Long-Term Liabilities	$11.94M	$9.421M	$9.421M
YoY Change	540.3%	347.17%	398.64%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.546M	$8.299M	$8.299M
Total Long-Term Liabilities	$11.94M	$9.421M	$9.421M
Total Liabilities	$20.49M	$17.72M	$17.72M
YoY Change	74.79%	15.09%	8.94%
SHAREHOLDERS EQUITY
Retained Earnings	-$43.19M	-$42.36M
YoY Change	-1.91%	-2.6%
Common Stock	$37.29M	$39.33M
YoY Change	0.0%	5.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$8.140M	-$6.200M	-$6.200M
YoY Change
Total Liabilities & Shareholders Equity	$12.35M	$11.52M	$11.52M
YoY Change	221.97%	75.51%	75.51%

Cashflow Statement

Concept	2024 Q2	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$363.4K	-$395.2K	$1.006M
YoY Change	56.55%	-462.67%	306.01%
Depreciation, Depletion And Amortization	$22.59K	$110.7K	$498.9K
YoY Change	-83.82%	-19.39%	-7.63%
Cash From Operating Activities	-$163.9K	$45.63K	-$530.2K
YoY Change	132.95%	-91.82%	-133.62%
INVESTING ACTIVITIES
Capital Expenditures	$26.42K	$5.870K	$40.60K
YoY Change	-185.83%	-80.89%	-87.14%
Acquisitions
YoY Change
Other Investing Activities	-$928.4K	-$15.00K	$7.704M
YoY Change		-95.67%	-2043.41%
Cash From Investing Activities	-$954.8K	-$20.87K	$2.455M
YoY Change	-1281.99%	-94.47%	-444.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.017M	22.25K	-$2.077M
YoY Change	-1199.02%	-124.87%	-784.01%
NET CHANGE
Cash From Operating Activities	-163.9K	45.63K	-$530.2K
Cash From Investing Activities	-954.8K	-20.87K	$2.455M
Cash From Financing Activities	1.017M	22.25K	-$2.077M
Net Change In Cash	-102.0K	47.01K	-$72.18K
YoY Change	24.15%	-48.52%	-178.52%
FREE CASH FLOW
Cash From Operating Activities	-$163.9K	$45.63K	-$530.2K
Capital Expenditures	$26.42K	$5.870K	$40.60K
Free Cash Flow	-$190.4K	$39.76K	-$570.8K
YoY Change	380.73%	-92.46%	-145.25%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0000792935
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent		usd
CY2023Q4	us-gaap	Secured Debt Current SecuredDebtCurrent		usd
CY2023Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent		usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities		usd
CY2023Q4	grst	Third Party Loans ThirdPartyLoans		usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Before Tax1 AccumulatedOtherComprehensiveIncomeLossBeforeTax1		usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest		usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense		usd
CY2023	grst	Forgiveness Of Government Relief Loan ForgivenessOfGovernmentReliefLoan		usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022	us-gaap	Loan Processing Fee LoanProcessingFee		usd
CY2023	us-gaap	Deferred Policy Acquisition Cost Foreign Currency Translation Adjustment And Other DeferredPolicyAcquisitionCostForeignCurrencyTranslationAdjustmentAndOther		usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets		usd
CY2022	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax		usd
CY2023	grst	Forgiveness Of Federal Relief Loan ForgivenessOfFederalReliefLoan		usd
CY2022	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred		usd
CY2022	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments		usd
CY2023	us-gaap	Proceeds From Sale Of Buildings ProceedsFromSaleOfBuildings		usd
CY2023	us-gaap	Proceeds From Other Deposits ProceedsFromOtherDeposits		usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2022	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022	grst	Fair Value Of Warrant Issued On Debt Extinguishment Non Cash Transactions FairValueOfWarrantIssuedOnDebtExtinguishmentNonCashTransactions		usd
CY2022	grst	Disposal Of Subsidiary To Related Party Non Cash Transactions DisposalOfSubsidiaryToRelatedPartyNonCashTransactions		usd
CY2022	grst	Deemed Extinguishment Of Debt By Related Party Non Cash Transactions DeemedExtinguishmentOfDebtByRelatedPartyNonCashTransactions		usd
CY2023	grst	Conversion Of Convertible Notes Non Cash Transactions ConversionOfConvertibleNotesNonCashTransactions		usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent		usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent		usd
CY2023Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent		usd
CY2023Q4	us-gaap	Principal Amount Outstanding On Loans Securitized PrincipalAmountOutstandingOnLoansSecuritized		usd
CY2023	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest		usd
CY2022	grst	Marktomarket Adjustments On Converted Notes MarktomarketAdjustmentsOnConvertedNotes		usd
CY2022	grst	Derivative Liability On Issued Convertible Notes DerivativeLiabilityOnIssuedConvertibleNotes		usd
CY2022	grst	Fair Value Adjustments To Derivative Liability FairValueAdjustmentsToDerivativeLiability		usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities		usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2022	grst	Exercise Price Per Share Granted ExercisePricePerShareGranted
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2022	grst	Exercised Per Share ExercisedPerShare
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023	grst	Exercised Per Share ExercisedPerShare
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2023	grst	Warrants Warrants		usd
CY2023	grst	Warrants Shares WarrantsShares		shares
CY2022	grst	Warrants Warrants		usd
CY2022	grst	Warrants Shares WarrantsShares		shares
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2023	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit		usd
CY2022	grst	Prior Year Over Provision PriorYearOverProvision		usd
CY2022	grst	Foreign Tax Rate Differential ForeignTaxRateDifferential		usd
CY2023	grst	Net Operating Loss Utilized NetOperatingLossUtilized		usd
CY2022	grst	Prior Year Net Operating Loss True Up PriorYearNetOperatingLossTrueUp		usd
CY2022	grst	Forfeiture Of Net Operating Loss On Disposal Of Subsidiary ForfeitureOfNetOperatingLossOnDisposalOfSubsidiary		usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance		usd
CY2023Q4	grst	Deferred Income Tax Assets Net1 DeferredIncomeTaxAssetsNet1		usd
CY2022	grst	Prior Year Adjustment To Opening Balance PriorYearAdjustmentToOpeningBalance		usd
CY2023	grst	Foreign Exchange Differentials ForeignExchangeDifferentials		usd
CY2023	grst	Net Disposals Asset And Liablities NetDisposalsAssetAndLiablities		usd
CY2022	grst	Net Disposals Asset And Liablities NetDisposalsAssetAndLiablities		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	2073714	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3729053805	shares
CY2023	dei	Auditor Name AuditorName	RBSM LLP
CY2023	dei	Auditor Firm AuditorFirmId	587
CY2023	dei	Auditor Location AuditorLocation	New York, NY
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	68573	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	140757	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	313338	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	337074	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	18159	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	44718	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	3030	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	20347	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	403100	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	542896	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	508401	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2974395	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	894952	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1252932	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9323723	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1393071	usd
CY2023Q4	us-gaap	Deposit Contracts Assets DepositContractsAssets	389000	usd
CY2022Q4	us-gaap	Deposit Contracts Assets DepositContractsAssets	400000	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	11116076	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	6020398	usd
CY2023Q4	us-gaap	Assets Assets	11519176	usd
CY2022Q4	us-gaap	Assets Assets	6563294	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	352101	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	170934	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	248644	usd
CY2023Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	4419927	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	5269250	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	680672	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	460534	usd
CY2022Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	3504605	usd
CY2023Q4	grst	Receivables Funding ReceivablesFunding	211961	usd
CY2022Q4	grst	Receivables Funding ReceivablesFunding	416731	usd
CY2023Q4	us-gaap	Government Assistance Amount Cumulative GovernmentAssistanceAmountCumulative	14962	usd
CY2022Q4	us-gaap	Government Assistance Amount Cumulative GovernmentAssistanceAmountCumulative	14818	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	38563	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	287017	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	8426	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	7891	usd
CY2022Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	194829	usd
CY2023Q4	grst	Related Party Payables RelatedPartyPayables	2572292	usd
CY2022Q4	grst	Related Party Payables RelatedPartyPayables	2713878	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8298904	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	13289131	usd
CY2023Q4	us-gaap	Government Assistance Amount Cumulative Noncurrent GovernmentAssistanceAmountCumulativeNoncurrent	20520	usd
CY2022Q4	us-gaap	Government Assistance Amount Cumulative Noncurrent GovernmentAssistanceAmountCumulativeNoncurrent	79555	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	217451	usd
CY2022Q4	grst	Third Party Loans ThirdPartyLoans	578335	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	9383557	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1206413	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	16475	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	24952	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	9420552	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2106706	usd
CY2023Q4	us-gaap	Liabilities Liabilities	17719456	usd
CY2022Q4	us-gaap	Liabilities Liabilities	15395837	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	4000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	4000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	4000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	4000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3729053805	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3729053805	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3729053805	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3729053805	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	37290539	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	37290539	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	26187925	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	23419917	usd
CY2023Q4	grst	Discount For Shares Issued Below Par Value DiscountForSharesIssuedBelowParValue	-27363367	usd
CY2022Q4	grst	Discount For Shares Issued Below Par Value DiscountForSharesIssuedBelowParValue	-27363367	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Before Tax1 AccumulatedOtherComprehensiveIncomeLossBeforeTax1	-5065	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-42355377	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-43484751	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-6200280	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-10102727	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	870184	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-6200280	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-9232543	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11519176	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6563294	usd
CY2023	us-gaap	Revenues Revenues	5344976	usd
CY2022	us-gaap	Revenues Revenues	4820747	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1041501	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	805372	usd
CY2023	us-gaap	Payments For Rent PaymentsForRent	614793	usd
CY2022	us-gaap	Payments For Rent PaymentsForRent	427482	usd
CY2023	us-gaap	Management Fee Expense ManagementFeeExpense	368003	usd
CY2022	us-gaap	Management Fee Expense ManagementFeeExpense	132500	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	707413	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	463678	usd
CY2023	us-gaap	Salaries And Wages SalariesAndWages	2656267	usd
CY2022	us-gaap	Salaries And Wages SalariesAndWages	1962479	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	498919	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	540119	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	5886896	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	4331630	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-541920	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	489117	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	15760	usd
CY2022	grst	Forgiveness Of Government Relief Loan ForgivenessOfGovernmentReliefLoan	104368	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	2484172	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-277175	usd
CY2023	us-gaap	Loan Processing Fee LoanProcessingFee	140000	usd
CY2023	grst	Penalty On Notes And Convertible Notes PenaltyOnNotesAndConvertibleNotes	-34688	usd
CY2022	grst	Penalty On Notes And Convertible Notes PenaltyOnNotesAndConvertibleNotes	-60075	usd
CY2023	us-gaap	Interest Income Other InterestIncomeOther	676	usd
CY2022	us-gaap	Interest Income Other InterestIncomeOther	78	usd
CY2023	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	500226	usd
CY2022	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	588477	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-281354	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-624683	usd
CY2023	grst	Foreign Exchange Movements ForeignExchangeMovements	-95032	usd
CY2022	grst	Foreign Exchange Movements ForeignExchangeMovements	1071320	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	614453	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	407408	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	391962	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-112220	usd
CY2023	us-gaap	Income Loss From Subsidiaries Net Of Tax IncomeLossFromSubsidiariesNetOfTax	1006415	usd
CY2022	us-gaap	Income Loss From Subsidiaries Net Of Tax IncomeLossFromSubsidiariesNetOfTax	295188	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	170184	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-47308	usd
CY2023	grst	Net Income Loss Stockholders NetIncomeLossStockholders	1176599	usd
CY2022	grst	Net Income Loss Stockholders NetIncomeLossStockholders	247880	usd
CY2023	us-gaap	Dividends Preferred Stock DividendsPreferredStock	47225	usd
CY2022	us-gaap	Dividends Preferred Stock DividendsPreferredStock	97782	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1129374	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	150098	usd
CY2022	us-gaap	Deferred Policy Acquisition Cost Foreign Currency Translation Adjustment And Other DeferredPolicyAcquisitionCostForeignCurrencyTranslationAdjustmentAndOther	821597	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1129374	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-671499	usd
CY2023	grst	Basic Loss Income Per Common Share BasicLossIncomePerCommonShare	0.00
CY2022	grst	Basic Loss Income Per Common Share BasicLossIncomePerCommonShare	0.00
CY2023	grst	Diluted Income Per Common Share DilutedIncomePerCommonShare	0.00
CY2022	grst	Diluted Income Per Common Share DilutedIncomePerCommonShare	0.00
CY2023	grst	Weighted Average Common Shares Outstanding Basic WeightedAverageCommonSharesOutstandingBasic	3729053805	shares
CY2022	grst	Weighted Average Common Shares Outstanding Basic WeightedAverageCommonSharesOutstandingBasic	3704807230	shares
CY2023	grst	Weighted Average Common Shares Outstanding Diluted WeightedAverageCommonSharesOutstandingDiluted	3903671684	shares
CY2022	grst	Weighted Average Common Shares Outstanding Diluted WeightedAverageCommonSharesOutstandingDiluted	4276363181	shares
CY2021Q4	grst	Stockholders Equity1 StockholdersEquity1	-9855381	usd
CY2022	us-gaap	Prior Period Reclassification Adjustment PriorPeriodReclassificationAdjustment	468462	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	150000	usd
CY2022	grst	Transactions With Related Parties TransactionsWithRelatedParties	628567	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent	-821597	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	295188	usd
CY2022	grst	Dividends Accrued DividendsAccrued	-97782	usd
CY2022Q4	grst	Stockholders Equity1 StockholdersEquity1	-9232543	usd
CY2023	grst	Disposal Of Subsidiary To Related Party DisposalOfSubsidiaryToRelatedParty	1334885	usd
CY2023	grst	Deemed Extinguishment Of Debt By Related Party DeemedExtinguishmentOfDebtByRelatedParty	461184	usd
CY2023	grst	Fair Value Of Warrants Issued On Debt Extinguishment FairValueOfWarrantsIssuedOnDebtExtinguishment	271939	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent	5065	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	1006415	usd
CY2023	grst	Dividends Accrued DividendsAccrued	-47225	usd
CY2023Q4	grst	Stockholders Equity1 StockholdersEquity1	-6200280	usd
CY2023	grst	Net Income Loss Available To Common Stockholders Basic1 NetIncomeLossAvailableToCommonStockholdersBasic1	1006415	usd
CY2022	grst	Net Income Loss Available To Common Stockholders Basic1 NetIncomeLossAvailableToCommonStockholdersBasic1	295188	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	498919	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	540119	usd
CY2023	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	281354	usd
CY2022	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	624683	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	2484172	usd
CY2023	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	-277175	usd
CY2022	grst	Forgiveness Of Federal Relief Loan ForgivenessOfFederalReliefLoan	104368	usd
CY2023	grst	Penalty On Promissory Notes PenaltyOnPromissoryNotes	34688	usd
CY2022	grst	Penalty On Promissory Notes PenaltyOnPromissoryNotes	60075	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	177220	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	260745	usd
CY2023	grst	Deferred Taxation Movement DeferredTaxationMovement	217451	usd
CY2022	grst	Deferred Taxation Movement DeferredTaxationMovement	55606	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-78037	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	215364	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-26562	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	14996	usd
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-5513	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	3113	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	201978	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	305785	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-179184	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-241083	usd
CY2023	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	-237211	usd
CY2022	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	125014	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-530157	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1577079	usd
CY2023	grst	Acquisition Of Real Property AcquisitionOfRealProperty	400000	usd
CY2022	grst	Acquisition Of Real Property AcquisitionOfRealProperty	400000	usd
CY2023	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	5209276	usd
CY2023	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	-8093448	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	40602	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	315822	usd
CY2022	grst	Net Of Cash Sale Subsidiary NetOfCashSaleSubsidiary	1421	usd
CY2022	us-gaap	Proceeds From Sale Of Buildings ProceedsFromSaleOfBuildings	1421	usd
CY2022	us-gaap	Proceeds From Other Deposits ProceedsFromOtherDeposits	4984	usd
CY2023	us-gaap	Payments To Acquire Restricted Certificates Of Deposit PaymentsToAcquireRestrictedCertificatesOfDeposit	389000	usd
CY2022	us-gaap	Payments To Acquire Restricted Certificates Of Deposit PaymentsToAcquireRestrictedCertificatesOfDeposit	400000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2454570	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-712259	usd
CY2023	us-gaap	Repayments Of First Mortgage Bond RepaymentsOfFirstMortgageBond	58320	usd
CY2022	us-gaap	Repayments Of First Mortgage Bond RepaymentsOfFirstMortgageBond	117073	usd
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	150000	usd
CY2023	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	1153666	usd
CY2023	us-gaap	Proceeds From Unsecured Notes Payable ProceedsFromUnsecuredNotesPayable	447000	usd
CY2022	us-gaap	Proceeds From Unsecured Notes Payable ProceedsFromUnsecuredNotesPayable	160000	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	568325	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	289044	usd
CY2023	grst	Proceeds From Receivables Funding ProceedsFromReceivablesFunding	580646	usd
CY2022	grst	Proceeds From Receivables Funding ProceedsFromReceivablesFunding	682500	usd
CY2023	grst	Repayment Of Receivables Funding RepaymentOfReceivablesFunding	994483	usd
CY2022	grst	Repayment Of Receivables Funding RepaymentOfReceivablesFunding	330312	usd
CY2023	grst	Repayment Of Government Assistance Loans RepaymentOfGovernmentAssistanceLoans	14579	usd
CY2022	grst	Repayment Of Government Assistance Loans RepaymentOfGovernmentAssistanceLoans	2970	usd
CY2023	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	283746	usd
CY2022	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	76856	usd
CY2023	grst	Repayment Of Finance Leases RepaymentOfFinanceLeases	7943	usd
CY2022	grst	Repayment Of Finance Leases RepaymentOfFinanceLeases	7437	usd
CY2023	grst	Repayment Proceeds From Related Party Notes RepaymentProceedsFromRelatedPartyNotes	174012	usd
CY2022	grst	Repayment Proceeds From Related Party Notes RepaymentProceedsFromRelatedPartyNotes	-284906	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2077428	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	303714	usd
CY2023	grst	Effect Of Exchanges Rate On Cash EffectOfExchangesRateOnCash	80831	usd
CY2022	grst	Effect Of Exchanges Rate On Cash EffectOfExchangesRateOnCash	-1076599	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-72184	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	91935	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	140757	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	48822	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	68573	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	140757	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	425117	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	234240	usd
CY2023	grst	Fair Value Of Warrant Issued On Debt Extinguishment Non Cash Transactions FairValueOfWarrantIssuedOnDebtExtinguishmentNonCashTransactions	271939	usd
CY2023	grst	Disposal Of Subsidiary To Related Party Non Cash Transactions DisposalOfSubsidiaryToRelatedPartyNonCashTransactions	1334885	usd
CY2023	grst	Deemed Extinguishment Of Debt By Related Party Non Cash Transactions DeemedExtinguishmentOfDebtByRelatedPartyNonCashTransactions	461184	usd
CY2022	grst	Conversion Of Convertible Notes Non Cash Transactions ConversionOfConvertibleNotesNonCashTransactions	150000	usd
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_800_eus-gaap--NatureOfOperations_zp9cihbsncMb" style="margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>1. <span id="xdx_82C_zxrH03CquKqa">Nature of business</span></b></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Since 2010, the Company has operated addiction treatment centers. Initially the Company operated an addiction treatment center in Ontario Canada under its Greenestone Muskoka clinic, which was sold on February 14, 2017. Simultaneously with this sale the Company purchased buildings and operated an addiction treatment center in Delray Beach Florida under its Addiction recovery Institute of America subsidiary with a license obtained in December 2016, initially though owned properties in Delray Beach and subsequently though leased properties in West Palm Beach, Florida. Since June 30, 2020, the Company has been actively involved in the management of a treatment center operated by Evernia in West Palm Beach Florida. On July 1, 2021, the Company closed on the acquisition of 75% of ATHI, which owns 100% of Evernia, once the probationary approval of a license was obtained from the Department of Children and Family Services of Florida. Evernia is currently the only active treatment center operated by the Company.</span></p> <p style="margin: 0 0 0 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0 0 0 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company sold its real estate on which its Greenstone Muskoka clinic operated during the current year, see note 4 below.</span></p> <p style="margin: 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"> </span></p>
CY2023Q4	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	2432514	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_840_eus-gaap--UseOfEstimates_zJGphtOX2B5g" style="margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>a) <span id="xdx_863_zPqIeOGNePQ3" style="background-color: white">Use of Estimates</span></b></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</span></p> <p style="margin: 0 0 0 45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Fdic Indemnification Asset FDICIndemnificationAsset	250000	usd
CY2023Q4	us-gaap	Disposal Group Including Discontinued Operation Property Plant And Equipment Current DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent	2420499	usd
CY2023Q4	grst	Wroking Captial Deficiency WrokingCaptialDeficiency	7400000	usd
CY2023Q4	grst	Liabilities In Excess Of Assets LiabilitiesInExcessOfAssets	6200000	usd
CY2023Q4	us-gaap	Disposal Group Including Discontinued Operation Accounts Notes And Loans Receivable Net DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet	12015	usd
CY2023Q4	us-gaap	Disposal Group Including Discontinued Operation Accounts Payable And Accrued Liabilities Current DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent	196859	usd
CY2023Q4	grst	Disposal Group Including Discontinued Operation Government Assistance Loans DisposalGroupIncludingDiscontinuedOperationGovernmentAssistanceLoans	-45317	usd
CY2023Q4	us-gaap	Disposal Group Including Discontinued Operation Other Noncurrent Liabilities DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities	3525223	usd
CY2023Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	3767399	usd
CY2023Q4	grst	Disposal Of Subsidiary To Related Party Recorded As Additional Paid In Capital DisposalOfSubsidiaryToRelatedPartyRecordedAsAdditionalPaidInCapital	-1334885	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2034885	usd
CY2023Q4	grst	Additional Paid In Capital1 AdditionalPaidInCapital1	461184	usd
CY2023Q4	grst	Government Assistance Amount Cumulative1 GovernmentAssistanceAmountCumulative1	50073	usd
CY2023	grst	Purchase Price PurchasePrice	5500000	usd
CY2023	grst	Fees And Expenses Related To Property Purchase FeesAndExpensesRelatedToPropertyPurchase	109276	usd
CY2023	us-gaap	Acquisition Costs AcquisitionCosts	5609276	usd
CY2023	us-gaap	Proceeds From Sale Of Other Real Estate ProceedsFromSaleOfOtherRealEstate	8500000	usd
CY2023	grst	Fees And Expenses Related To Disposal Of Property FeesAndExpensesRelatedToDisposalOfProperty	-406552	usd
CY2023	us-gaap	Gain Loss On Sale Of Unproved Property GainLossOnSaleOfUnprovedProperty	8093448	usd
CY2023	grst	Deferred Gain On Sale Of Property One DeferredGainOnSaleOfPropertyOne	2484172	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	675147	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	166746	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	508401	usd
CY2022Q4	grst	Property Plant And Equipment Net1 PropertyPlantAndEquipmentNet1	2974395	usd
CY2023	us-gaap	Depreciation Depreciation	140939	usd
CY2022	us-gaap	Depreciation Depreciation	182139	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1789903	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	894951	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	894952	usd
CY2022Q4	grst	Finite Lived Intangible Assets Net1 FiniteLivedIntangibleAssetsNet1	125293	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	357981	usd
CY2023Q4	us-gaap	Present Value Of Future Insurance Profits Amortization Expense Year One PresentValueOfFutureInsuranceProfitsAmortizationExpenseYearOne	357981	usd
CY2023Q4	us-gaap	Present Value Of Future Insurance Profits Amortization Expense Year Two PresentValueOfFutureInsuranceProfitsAmortizationExpenseYearTwo	357981	usd
CY2023Q4	us-gaap	Present Value Of Future Insurance Profits Amortization Expense Year Three PresentValueOfFutureInsuranceProfitsAmortizationExpenseYearThree	178990	usd
CY2023Q4	grst	Total Estimated Amortization Expense TotalEstimatedAmortizationExpense	894952	usd
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	24901	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	38079	usd
CY2023Q4	grst	Rightofuse Assets Operating Leases Net Of Amortization RightofuseAssetsOperatingLeasesNetOfAmortization	9323723	usd
CY2022Q4	grst	Rightofuse Assets Operating Leases Net Of Amortization RightofuseAssetsOperatingLeasesNetOfAmortization	1393071	usd
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	11190	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	11190	usd
CY2023	grst	Interest Expense On Finance Lease Liabilities InterestExpenseOnFinanceLeaseLiabilities	1938	usd
CY2022	grst	Interest Expense On Finance Lease Liabilities InterestExpenseOnFinanceLeaseLiabilities	2443	usd
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	13128	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	13633	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	598336	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	400207	usd
CY2023	us-gaap	Lease Cost LeaseCost	611464	usd
CY2022	us-gaap	Lease Cost LeaseCost	413840	usd
CY2023	grst	Operating Cash Flows From Finance Leases OperatingCashFlowsFromFinanceLeases	-1938	usd
CY2022	grst	Operating Cash Flows From Finance Leases OperatingCashFlowsFromFinanceLeases	-2443	usd
CY2023	grst	Operating Cash Flows From Operating Leases OperatingCashFlowsFromOperatingLeases	-600299	usd
CY2022	grst	Operating Cash Flows From Operating Leases OperatingCashFlowsFromOperatingLeases	-380545	usd
CY2023	grst	Financing Cash Flows From Finance Leases FinancingCashFlowsFromFinanceLeases	-7891	usd
CY2022	grst	Financing Cash Flows From Finance Leases FinancingCashFlowsFromFinanceLeases	-7437	usd
CY2023	grst	Financing Cash Flows From Finance Leases Net FinancingCashFlowsFromFinanceLeasesNet	-610127	usd
CY2022	grst	Financing Cash Flows From Finance Leases Net FinancingCashFlowsFromFinanceLeasesNet	-390425	usd
CY2023	grst	Weighted Average Lease Term Finance Leases WeightedAverageLeaseTermFinanceLeases	2 years and ten months
CY2022	grst	Weighted Average Lease Term Finance Leases WeightedAverageLeaseTermFinanceLeases	3 years and ten months
CY2023	grst	Weighted Average Remaining Lease Term Operating Leases WeightedAverageRemainingLeaseTermOperatingLeases	19 years and 8 months
CY2022	grst	Weighted Average Remaining Lease Term Operating Leases WeightedAverageRemainingLeaseTermOperatingLeases	4 years and 1 months
CY2023	grst	Discount Rate Finance Leases DiscountRateFinanceLeases	0.0660	pure
CY2022	grst	Discount Rate Finance Leases DiscountRateFinanceLeases	0.0660	pure
CY2023	grst	Discount Rate Operating Leases DiscountRateOperatingLeases	0.077	pure
CY2022	grst	Discount Rate Operating Leases DiscountRateOperatingLeases	0.0464	pure
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	9829	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	9829	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	6195	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	1707	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	27560	usd
CY2023Q4	grst	Imputed Interest ImputedInterest	-2659	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	24901	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	8426	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	16475	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	24901	usd
CY2023Q4	us-gaap	Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear	754857	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	775615	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	796945	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	818861	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	16200042	usd
CY2023Q4	grst	Total Undiscounted Minimum Future Lease Payments TotalUndiscountedMinimumFutureLeasePayments	19346320	usd
CY2023Q4	grst	Imputed Interest1 ImputedInterest1	9924200	usd
CY2023Q4	grst	Lessee Operating Lease Liability Payments Due One LesseeOperatingLeaseLiabilityPaymentsDueOne	9422120	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	38563	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	9383557	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	9422120	usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	74134	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	174510	usd
CY2022Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	248644	usd
CY2023	grst	Debt Instrument Of Principal Amount DebtInstrumentOfPrincipalAmount	3419776	usd
CY2023	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	1000151	usd
CY2023	grst	Shortterm Convertible ShorttermConvertible	4419927	usd
CY2022	grst	Shortterm Convertible ShorttermConvertible	5269250	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.001
CY2023Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.042	pure
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	515901	usd
CY2022	grst	Elimination Of Derivative Liability On Adoption EliminationOfDerivativeLiabilityOnAdoption	-515901	usd
CY2023	grst	Due To Related Parties DueToRelatedParties	2572292	usd
CY2022	grst	Due To Related Parties DueToRelatedParties	2713878	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0431	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0487	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	2.055	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	2.430	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	623777506	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.0052875
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	20925000	shares
CY2022	grst	Forfeitedcancelled Forfeitedcancelled	0.12
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.12
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	602852506	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.001306
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	745810761	shares
CY2023	grst	Exercise Price Per Share Granted ExercisePricePerShareGranted	0.001
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.001
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	326286847	shares
CY2023	grst	Forfeitedcancelled Forfeitedcancelled	0.000675
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.000675
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1022376420	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.0012840
CY2023	grst	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceTerm	P3Y6M
CY2023	grst	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price Term1 ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceTerm1	P2Y3D
CY2023	grst	Warrants Outstanding WarrantsOutstanding	1022376420	shares
CY2023	grst	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price Term2 ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceTerm2	P3Y1M6D
CY2023Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.001284
CY2023	grst	Warrants Exercisable WarrantsExercisable	1022376420	shares
CY2023	grst	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Exercisable ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExercisable	0.001284
CY2023	grst	Net Income Per Share Available For Common Stockholders Amount NetIncomePerShareAvailableForCommonStockholdersAmount	1129374	usd
CY2023	grst	Net Income Per Share Available For Common Stockholders Shares NetIncomePerShareAvailableForCommonStockholdersShares	3729053805	shares
CY2023	grst	Net Income Per Share Available For Common Stockholders Per Share NetIncomePerShareAvailableForCommonStockholdersPerShare	0.00
CY2023	grst	Convertible Debt Amount ConvertibleDebtAmount	198684	usd
CY2023	grst	Convertible Debt Shares ConvertibleDebtShares	174617879	shares
CY2023	grst	Net Income Per Share Available For Common Stockholders Diluted Amount NetIncomePerShareAvailableForCommonStockholdersDilutedAmount	1328058	usd
CY2023	grst	Net Income Per Share Available For Common Stockholders Diluted Shares NetIncomePerShareAvailableForCommonStockholdersDilutedShares	3903671684	shares
CY2023	grst	Net Income Per Share Available For Common Stockholders Diluted Per Shares NetIncomePerShareAvailableForCommonStockholdersDilutedPerShares	0.00
CY2022	grst	Net Income Per Share Available For Common Stockholders Amount NetIncomePerShareAvailableForCommonStockholdersAmount	150098	usd
CY2022	grst	Net Income Per Share Available For Common Stockholders Shares NetIncomePerShareAvailableForCommonStockholdersShares	3704807230	shares
CY2022	grst	Net Income Per Share Available For Common Stockholders Per Share NetIncomePerShareAvailableForCommonStockholdersPerShare	0.00
CY2022	grst	Convertible Debt Amount ConvertibleDebtAmount	820739	usd
CY2022	grst	Convertible Debt Shares ConvertibleDebtShares	571555951	shares
CY2022	grst	Net Income Per Share Available For Common Stockholders Diluted Amount NetIncomePerShareAvailableForCommonStockholdersDilutedAmount	970837	usd
CY2022	grst	Net Income Per Share Available For Common Stockholders Diluted Shares NetIncomePerShareAvailableForCommonStockholdersDilutedShares	4276363181	shares
CY2022	grst	Net Income Per Share Available For Common Stockholders Diluted Per Shares NetIncomePerShareAvailableForCommonStockholdersDilutedPerShares	0.00
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	174511	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	174511	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	217451	usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	217451	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	391962	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-129035	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-85555	usd
CY2023	grst	State Taxation StateTaxation	55679	usd
CY2022	grst	State Taxation StateTaxation	-29345	usd
CY2023	grst	Prior Year Over Provision PriorYearOverProvision	174511	usd
CY2023	grst	Permanent Differences PermanentDifferences	-257015	usd
CY2022	grst	Permanent Differences PermanentDifferences	235762	usd
CY2023	grst	Foreign Tax Rate Differential ForeignTaxRateDifferential	-181036	usd
CY2022	grst	Net Operating Loss Utilized NetOperatingLossUtilized	-233082	usd
CY2023	grst	Prior Year Net Operating Loss True Up PriorYearNetOperatingLossTrueUp	571391	usd
CY2023	grst	Forfeiture Of Net Operating Loss On Disposal Of Subsidiary ForfeitureOfNetOperatingLossOnDisposalOfSubsidiary	-178608	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	336075	usd
CY2023	grst	Net Tax Benefit Expense NetTaxBenefitExpense	391962	usd
CY2022	grst	Net Tax Benefit Expense NetTaxBenefitExpense	-112220	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	105801	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other Finite Lived Assets DeferredTaxLiabilitiesOtherFiniteLivedAssets	158108	usd
CY2023Q4	grst	Net Operating Losses One NetOperatingLossesOne	6192106	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other Comprehensive Income DeferredTaxLiabilitiesOtherComprehensiveIncome	24993	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6269406	usd
CY2023	grst	Net Operating Loss Carry Forward One NetOperatingLossCarryForwardOne	31077947	usd
CY2022	grst	Net Operating Loss Carry Forward One NetOperatingLossCarryForwardOne	34945459	usd
CY2023	grst	Prior Year Adjustment To Opening Balance PriorYearAdjustmentToOpeningBalance	1729182	usd
CY2022	grst	Foreign Exchange Differentials ForeignExchangeDifferentials	-105379	usd
CY2023	grst	Net Operating Loss Utilized One NetOperatingLossUtilizedOne	-3291537	usd
CY2022	grst	Net Operating Loss Utilized One NetOperatingLossUtilizedOne	-3514804	usd
CY2023	grst	Net Taxable Losses NetTaxableLosses	558507	usd
CY2022	grst	Net Taxable Losses NetTaxableLosses	4624718	usd
CY2023	grst	Disposal Of Subsidiary DisposalOfSubsidiary	-673992	usd
CY2022	grst	Disposal Of Subsidiary DisposalOfSubsidiary	-4872047	usd
CY2023	grst	Federal Net Operatings FederalNetOperatings	24400107	usd
CY2022	grst	Federal Net Operatings FederalNetOperatings	31077947	usd
CY2023	grst	Valuation Allowances ValuationAllowances	-29400107	usd
CY2022	grst	Valuation Allowances ValuationAllowances	-31077947	usd

Files In Submission

Name	View Source	Status
0001903596-24-000279-index-headers.html	Edgar Link	pending
0001903596-24-000279-index.html	Edgar Link	pending
0001903596-24-000279.txt	Edgar Link	pending
0001903596-24-000279-xbrl.zip	Edgar Link	pending
ex31.htm	Edgar Link	pending
ex32.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
grst-20231231.xsd	Edgar Link	pending
grst-20231231_def.xml	Edgar Link	unprocessable
grst-20231231_lab.xml	Edgar Link	unprocessable
grst_1.jpg	Edgar Link	pending
grst_10k.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
grst_10k_htm.xml	Edgar Link	completed
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
grst-20231231_cal.xml	Edgar Link	unprocessable
grst-20231231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GRST
ETHEMA HEALTH Corp Stock $grst

2024 Q2 Form 10-K Financial Statement

#000190359624000279 Filed on May 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GRST ETHEMA HEALTH Corp Stock $grst

2024 Q2 Form 10-K Financial Statement

#000190359624000279 Filed on May 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GRST
ETHEMA HEALTH Corp Stock $grst